Menu
GeneBe

rs199473286

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP2PP3_StrongPP5

The NM_001099404.2(SCN5A):c.4895G>A(p.Arg1632His) variant causes a missense change. The variant allele was found at a frequency of 0.00000806 in 1,613,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 14/23 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1632C) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000082 ( 0 hom. )

Consequence

SCN5A
NM_001099404.2 missense

Scores

15
1
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:9U:1O:1

Conservation

PhyloP100: 6.07
Variant links:
Genes affected
SCN5A (HGNC:10593): (sodium voltage-gated channel alpha subunit 5) The protein encoded by this gene is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. This protein is found primarily in cardiac muscle and is responsible for the initial upstroke of the action potential in an electrocardiogram. Defects in this gene have been associated with long QT syndrome type 3 (LQT3), atrial fibrillation, cardiomyopathy, and Brugada syndrome 1, all autosomal dominant cardiac diseases. Alternative splicing results in several transcript variants encoding different isoforms. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 12 uncertain in NM_001099404.2
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr3-38551478-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 242199.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP2
Missense variant where missense usually causes diseases, SCN5A
PP3
MetaRNN computational evidence supports a deleterious effect, 0.993
PP5
Variant 3-38551477-C-T is Pathogenic according to our data. Variant chr3-38551477-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 67939.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=6, Uncertain_significance=1, not_provided=1, Pathogenic=3}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SCN5ANM_001099404.2 linkuse as main transcriptc.4895G>A p.Arg1632His missense_variant 28/28 ENST00000413689.6
SCN5ANM_000335.5 linkuse as main transcriptc.4892G>A p.Arg1631His missense_variant 28/28 ENST00000423572.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SCN5AENST00000413689.6 linkuse as main transcriptc.4895G>A p.Arg1632His missense_variant 28/285 NM_001099404.2 P4
SCN5AENST00000423572.7 linkuse as main transcriptc.4892G>A p.Arg1631His missense_variant 28/281 NM_000335.5 A1Q14524-2

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
152066
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000796
AC:
2
AN:
251374
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
135856
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000821
AC:
12
AN:
1461798
Hom.:
0
Cov.:
35
AF XY:
0.00000688
AC XY:
5
AN XY:
727188
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000809
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
152066
Hom.:
0
Cov.:
31
AF XY:
0.0000135
AC XY:
1
AN XY:
74264
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:9Uncertain:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Pathogenic:3
Likely pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityDec 30, 2021- -
Pathogenic, criteria provided, single submitterclinical testingInvitaeOct 18, 2023This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1632 of the SCN5A protein (p.Arg1632His). This variant is present in population databases (rs199473286, gnomAD 0.003%). This missense change has been observed in individuals with Brugada syndrome or sick sinus syndrome (PMID: 14523039, 24948852, 28781330, 34539730, 35027292, 35124229). ClinVar contains an entry for this variant (Variation ID: 67939). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (PMID: 32533946) indicates that this missense variant is expected to disrupt SCN5A function. Experimental studies have shown that this missense change affects SCN5A function (PMID: 20384651, 20539757, 32533946). This variant disrupts the p.Arg1632 amino acid residue in SCN5A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 26031372, 27082542, 31191357). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingGeneDxJun 21, 2022Observed in the heterozygous state in patients with Brugada syndrome and in the compound heterozygous state with a second SCN5A variant in patients with sick sinus syndrome, and segregated with SCN5A-related phenotypes in relatives from unrelated families in the published literature (Benson et al., 2003; van Malderen et al., 2017; Robyns et al., 2014; Robyns et al., 2018; Liu et al., 2021); Published functional studies demonstrate a damaging effect on channel kinetics (Benson et al., 2003; Gui et al., 2010); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 27381756, 20384651, 25863800, 20539757, 28018021, 17368591, 31521807, 32850980, 31447099, 33131149, 29709101, 29728395, 24948852, 28781330, 26582918, 14523039, 34539730) -
Brugada syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingClinical Genomics Laboratory, Washington University in St. LouisAug 29, 2023The SCN5A c.4892G>A (p.Arg1631His) variant, also published as Arg1632His, has been reported in at least four individuals and families affected with sick sinus syndrome or Brugada syndrome (Benson DW et al., PMID: 14523039; Liu Y et al., PMID: 34539730; Robyns T et al., PMID: 24948852; Van Malderen SCH et al., PMID: 28781330). This variant has been reported in the ClinVar database as a germline pathogenic variant by one submitter, a likely pathogenic variant by five submitters, and a variant of uncertain significance by one submitter. Computational predictors indicate that the variant is damaging, evidence that correlates with impact to SCN5A function. In support of this prediction, functional studies have shown this variant effects cardiac sodium channel kinetics (Glazer AM et al., PMID: 32533946; Gui J et al., PMID: 20384651; Gui J et al., PMID: 20539757). Another variant in the same codon, p.Arg1631Cys, has also been reported in affected individuals (García-Molina E at al., PMID: 27082542; Nakajima T et al., PMID: 26031372). This variant is only observed on 2/251,374 alleles in the general population (gnomAD v.2.1.1), indicating it is not a common variant. Based on available information and the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), this variant is classified as pathogenic. -
Brugada syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthFeb 05, 2024This missense variant replaces arginine with histidine at codon 1632 of the SCN5A protein. This variant is also known as p.Arg1631His in the literature based on a different NM_000335 transcript. This variant is found within a highly conserved region (a.a.1530-1771) in the transmembrane domain DIV. Rare non-truncating variants in this region have been shown to be significantly overrepresented in individuals with Brugada syndrome (PMID: 32893267). In vitro functional studies have shown that this variant leads to profound impairment in channel function (PMID: 14523039, 20539757, 32533946). This variant has been reported in at least eight individuals affected with Brugada syndrome from five families (PMID: 24948852, 28781330, 29709101, 32893267, 37061847), in two young individuals affected with sick sinus syndrome, one of which was compound heterozygous for this variant and another pathogenic variant (PMID: 14523039, 34539730), and in two infants affected with sudden unexpected death (PMID: 35027292, Clinvar SCV002030070.1). It has been shown that this variant segregates with SCN5A-related phenotypes in one of the families including four carriers who were affected with Brugada syndrome, sick sinus syndrome, or progressive familial heart block (PMID: 24948852). This variant has been identified in 2/251374 chromosomes in the general population by the Genome Aggregation Database (gnomAD). A different missense variant occurring at the same codon, p.Arg1632Cys, is known to be pathogenic (Clinvar variation ID 242199), indicating that arginine at this position is important for SCN5A protein function. Based on the available evidence, this variant is classified as Likely Pathogenic. -
Sick sinus syndrome 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingBeijing Key Laboratry for Genetics of Birth Defects, Beijing Children's HospitalFeb 28, 2020- -
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsJun 08, 2023The p.R1632H variant (also known as c.4895G>A), located in coding exon 27 of the SCN5A gene, results from a G to A substitution at nucleotide position 4895. The arginine at codon 1632 is replaced by histidine, an amino acid with highly similar properties, and is located in the DIV-S4 transmembrane region. This alteration has been reported in multiple probands with SCN5A-related arrhythmia including sick sinus syndrome and Brugada syndrome (Benson DW et al. J. Clin. Invest. 2003;112:1019-28; Robyns T et al. Indian Pacing Electrophysiol J. 2014;14:133-49; Van Malderen SCH et al. Circ. J. 2017;82:53-61; Liu Y et al. Front Genet. 2021 Sep;12:677699; Ambry internal data). Functional studies suggest this alteration impairs recovery from inactivation and current density; however, the physiological relevance of these results is unclear (Benson DW et al. J. Clin. Invest. 2003;112:1019-28; Gui J et al. PLoS ONE. 2010;5:e10985; Glazer AM et al. Am. J. Hum. Genet. 2020 Jul;107(1):111-123). In addition, a deep mutational scanning study categorized this alteration as a possible loss of function alteration (Glazer AM et al. Circ Genom Precis Med, 2020 02;13:e002786). Based on internal structural analysis, the arginine impacted by this alteration is part of a highly conserved set of residues that generate a characteristic motif necessary to the function of voltage-sensing channels, and this variant is predicted to disrupt voltage gating activity (Gandhi CS et al. J. Gen. Physiol., 2002 Oct;120:455-63; Starace DM et al. Nature, 2004 Feb;427:548-53; DeCaen PG et al. Proc Natl Acad Sci U S A. 2008 Sep;105(39):15142-7; Ambry internal data). In addition, other variants affecting this codon (p.R1632L, c.4895G>T and p.R1632C, c.4894C>T) have been reported in association with Brugada syndrome (Batchvarov VN et al. J Electrocardiol;44:308; Nakajima T et al. Heart Rhythm. 2015 Nov;12(11):2296-304; Van Malderen SCH et al. Circ. J. 2017;82:53-61). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Cardiac arrhythmia Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthSep 18, 2023This missense variant replaces arginine with histidine at codon 1632 of the SCN5A protein. This variant is also known as p.Arg1631His in the literature based on a different NM_000335 transcript. This variant is found within a highly conserved region (a.a.1530-1771) in the transmembrane domain DIV. Rare non-truncating variants in this region have been shown to be significantly overrepresented in individuals with Brugada syndrome (PMID: 32893267). In vitro functional studies have shown that this variant leads to profound impairment in channel function (PMID: 14523039, 20539757, 32533946). This variant has been reported in at least eight individuals affected with Brugada syndrome from five families (PMID: 24948852, 28781330, 29709101, 32893267, 37061847), in two young individuals affected with sick sinus syndrome, one of which was compound heterozygous for this variant and another pathogenic variant (PMID: 14523039, 34539730), and in two infants affected with sudden unexpected death (PMID: 35027292, Clinvar SCV002030070.1). It has been shown that this variant segregates with SCN5A-related phenotypes in one of the families including four carriers who were affected with Brugada syndrome, sick sinus syndrome, or progressive familial heart block (PMID: 24948852). This variant has been identified in 2/251374 chromosomes in the general population by the Genome Aggregation Database (gnomAD). A different missense variant occurring at the same codon, p.Arg1632Cys, is known to be pathogenic (Clinvar variation ID 242199), indicating that arginine at this position is important for SCN5A protein function. Based on the available evidence, this variant is classified as Likely Pathogenic. -
Long QT syndrome 3;C4551804:Brugada syndrome 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingHuman Genome Sequencing Center Clinical Lab, Baylor College of MedicineAug 22, 2018This c.4895G>A (p.Arg1632His) variant in exon 28 of the SCN5A gene results in an amino acid change at residue 1632 of an arginine to a histidine. This variant has been observed in patients with sick sinus syndrome and Brugada syndrome (PMID: 14523039, 24948852) and is rarely observed in general population databases. Functional studies have shown a strong effect on cardiac sodium channel kinetics (PMID: 20539757). Therefore, the c.4895G>A (p.Arg1632His) variant in the SCN5A gene is classified as likely pathogenic. -
SUDDEN INFANT DEATH SYNDROME Uncertain:1
Uncertain significance, criteria provided, single submitterresearchRobert's Program, Boston Children's HospitalOct 01, 2021We classify this variant as a variant of uncertain significance using ACMG/AMP criteria. As this variant has functional evidence supporting pathogenicty, we suspect this variant is favoring pathogenic. -
Conduction system disorder Other:1
not provided, no classification providedliterature onlyCardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust-This variant has been reported in the following publications (PMID:14523039;PMID:20384651;PMID:20539757). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
CardioboostArm
Pathogenic
1.0
CardioboostCm
Pathogenic
0.97
BayesDel_addAF
Pathogenic
0.50
D
BayesDel_noAF
Pathogenic
0.57
Cadd
Pathogenic
30
Dann
Pathogenic
1.0
Eigen
Pathogenic
0.89
Eigen_PC
Pathogenic
0.78
FATHMM_MKL
Uncertain
0.96
D
M_CAP
Pathogenic
0.97
D
MetaRNN
Pathogenic
0.99
D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
0.95
D
MutationTaster
Benign
1.0
D;D;D;D;D;D;D;D;D;D
PrimateAI
Pathogenic
0.84
D
PROVEAN
Pathogenic
-4.6
D;D;D;D;D;D;D;D;D
REVEL
Pathogenic
0.98
Sift
Pathogenic
0.0
D;D;D;D;D;D;D;D;D
Sift4G
Benign
0.083
T;T;T;T;T;T;T;T;T
Polyphen
1.0
D;D;.;D;.;D;D;.;.
Vest4
0.97
MutPred
0.98
.;.;Gain of methylation at R1629 (P = 0.0457);.;.;Gain of methylation at R1629 (P = 0.0457);.;.;.;
MVP
0.99
MPC
1.6
ClinPred
1.0
D
GERP RS
4.5
Varity_R
0.88
gMVP
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199473286; hg19: chr3-38592968; COSMIC: COSV61122853; COSMIC: COSV61122853; API